You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 30, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Zuriñe Erana-Perez1, Manoli Igartua2, Edorta Santos-Vizcaino2
1NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain; Bioaraba, NanoBioCel Research Group, 01006 Vitoria-Gasteiz, Spain.
Extracellular vesicles (EVs) show promise for drug delivery. Genetic engineering of parent cells (endogenous loading) offers advantages for loading large therapeutic molecules compared to external (exogenous) methods.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: